United States - English - NLM (National Library of Medicine)

northstar rx llc - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride tablet is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. tiagabine hydrochloride is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of tiagabine hydrochloride have not been evaluated in human studies.

United States - English - NLM (National Library of Medicine)

stat rx usa llc - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine 12 mg - gabitril (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. gabitril is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabitril have not been evaluated in human studies.

United States - English - NLM (National Library of Medicine)

cephalon, llc - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride 2 mg - gabitril (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. gabitril is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabitril have not been evaluated in human studies.

United States - English - NLM (National Library of Medicine)

carilion materials management - tiagabine hydrochloride (unii: dqh6t6d8oy) (tiagabine - unii:z80i64hmnp) - tiagabine hydrochloride 4 mg - gabitril (tiagabine hydrochloride) is indicated as adjunctive therapy in adults and children 12 years and older in the treatment of partial seizures. gabitril is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of gabitril have not been evaluated in human studies.

Australia - English - Department of Health (Therapeutic Goods Administration)

juniper biologics pty ltd - chlormethine hydrochloride, quantity: 0.2 mg/g (equivalent: chlormethine, qty 0.16 mg/g) - gel - excipient ingredients: butylated hydroxytoluene; disodium edetate; diethylene glycol monoethyl ether; isopropyl alcohol; hyprolose; lactic acid; propylene glycol; glycerol; menthol; sodium chloride - ledaga is indicated for the topical treatment of mycosis fungoides-type cutaneous t-cell lymphoma (mf-type ctcl) in adult patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - tiagabine hydrochloride monohydrate, quantity: 17.2 mg (equivalent: tiagabine, qty 15 mg) - tablet, film coated - excipient ingredients: ascorbic acid; stearic acid; crospovidone; magnesium stearate; colloidal anhydrous silica; hydrogenated vegetable oil; lactose; pregelatinised maize starch; microcrystalline cellulose; hypromellose; hyprolose; titanium dioxide - for the treatment of partial seizures, as add on therapy in patients who are not controlled satisfactorily with other antiepileptic drug(s).

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - tiagabine hydrochloride monohydrate, quantity: 11.5 mg (equivalent: tiagabine, qty 10 mg) - tablet, film coated - excipient ingredients: ascorbic acid; crospovidone; hydrogenated vegetable oil; magnesium stearate; microcrystalline cellulose; hypromellose; stearic acid; hyprolose; titanium dioxide; lactose; pregelatinised maize starch; colloidal anhydrous silica - for the treatment of partial seizures, as add on therapy in patients who are not controlled satisfactorily with other antiepileptic drug(s).

Australia - English - Department of Health (Therapeutic Goods Administration)

teva pharma australia pty ltd - tiagabine hydrochloride monohydrate, quantity: 5.73 mg (equivalent: tiagabine, qty 5 mg) - tablet, film coated - excipient ingredients: hypromellose; lactose; hyprolose; stearic acid; crospovidone; pregelatinised maize starch; microcrystalline cellulose; hydrogenated vegetable oil; colloidal anhydrous silica; magnesium stearate; ascorbic acid; titanium dioxide - for the treatment of partial seizures, as add on therapy in patients who are not controlled satisfactorily with other antiepileptic drug(s).

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

pharmacor pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: maize starch; lactose; purified talc; titanium dioxide; purified water; iron oxide yellow; iron oxide red; gelatin; sodium lauryl sulfate - pharmagabapentin is indicated for the treatment of,? partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children age 3 years and above who have not achieved adequate control with standard anti-epileptic drugs.,? neuropathic pain.